In The News | Our News | Events

For NHS Trusts and healthcare bodies across Europe, making the move to digital pathology has been a huge undertaking, but there is sill much to learn.

Digital pathology (DP) adoption is continuing to scale dramatically, with the global market reporting growth of 37.3%, 31.4% and 27.3% over the last three consecutive years, as shown in Figure 1.

Our research has highlighted that EHRs are the main sources of patient information that are used to identify specific patient cohorts to target as part of VBC, coupled with manual data handling processes. Some EHRs are basic without clinical decision support (CDS) tools for closing care gaps.

Software multinational SAP's late 2022 announcement that it would cease supporting Oracle Cerner's i.s.h.med EHR solution by 2030 required a swift and decisive response from Oracle Cerner.

Independent software vendors (ISVs) developing AI image analysis solutions for medical imaging have raised almost $5 billion in venture capital (VC) funding since 2015. There are over 200 ISVs, most of which are startups, but some have started to mature, with the top 25 companies accounting for 73% of the total VC funding raised ($3.6 billion).

In the past decade, the trend toward enterprise imaging has mainly focused on connecting the various modalities in radiology into one centralized image and report repository.

Venture capital firms have poured nearly $5 billion into imaging artificial intelligence companies since 2015 with a marked change in deal sizes this year, according to new research.

VC investment in the AI medical imaging sector has shifted notably in the last couple years, says a new report from UK market intelligence firm Signify Research. The report offers a fascinating look at an industry where almost $5B has been raised since 2015.

The use of wearable technology in healthcare is continuing to evolve with high interest, driving technology innovation and advancing solutions to enable clinical grade measurements to support patient care in the home.

Value-based care (VBC) is a healthcare delivery model that differs from traditional fee-for-service because rather than compensating providers based on the number of services provided, it ties the amount providers earn to the results they deliver for their patients.

Despite declining tobacco use, lung cancer remains the leading cause of cancer deaths globally, often evading detection until advanced stages. It is unsurprising, then, that interest in targeted lung screening (LCS) programs has risen markedly in recent decades.